Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, with repeat dosing of DeltEx™ Drug-Resistant ...

LONDON, Feb. 17, 2026 /PRNewswire/ -- Resurrect Bio, a biotechnology company revolutionizing agriculture by equipping crops with genetic defenses against disease, today announced the successful ...

Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating ...

Maharashtra HSC Biology Question Paper 2026 with answer key is available here . Check answers curated by subject experts. Estimate your score before the Maharashtra HSC results.

UP Board Exams 2026: The Uttar Pradesh Madhyamik Shiksha Parishad (UPMSP) is conducting the UP-Board Class 10 English examination along with the Class 12 Mathematics and Biology papers on February 23, ...

The Board of Secondary Education Karachi has released the Class 9 Science Group exam schedule for 2026. Exams begin April 8, running through April 23, morning session 9:30 am to 12:30 pm.

In the middle of the winter blues, the University of Connecticut’s Horticulture Club, in collaboration with the Department of Plant Science and Landscape Architecture, presented a full-scale ...

ImageneBio, Inc. (Nasdaq: IMA) ('Imagene” or the 'Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a company update.

Partnership leverages Tenacia's expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights ...

Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsRoopal Thakkar - Executive VP of Research ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...